Systematic review with meta-analysis: Post-infectious functional dyspepsia

Alimentary Pharmacology and Therapeutics

Volumn 41, Issue 2, 2015, Pages 177-188

  Futagami, S ^a   Itoh, T ^a   Sakamoto, C ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GASTROENTERITIS; ARTICLE; CAMPYLOBACTER JEJUNI; CELL INFILTRATION; DYSPEPSIA; ESCHERICHIA COLI; GIARDIA LAMBLIA; HUMAN; INFLAMMATORY CELL; IRRITABLE COLON; NOROVIRUS; PREVALENCE; SALMONELLA; STOMACH EMPTYING; SYMPTOM; SYSTEMATIC REVIEW; BACTERIAL INFECTIONS; CASE CONTROL STUDY; COMPLICATION; GASTROENTERITIS; IRRITABLE BOWEL SYNDROME; META ANALYSIS; RISK;

BACTERIAL INFECTIONS; CASE-CONTROL STUDIES; DYSPEPSIA; GASTROENTERITIS; HUMANS; IRRITABLE BOWEL SYNDROME; ODDS RATIO; PREVALENCE;

EID: 84918517823     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.13006     Document Type: Article

References (68)

1. Talley NJ, Vakil NB, Moayyedi P,. American Gastroenterological Association technical review on the evaluation of dyspepsia. Gastroenterology 2005; 129: 1756-80.
2. Talley NJ, Stanghellini V, Heading RC, Koch KL, Malagelada JR, Tytgat GN,. Functional gastroduodenal disorders. Gut 1999; 45 (Suppl. 2): 37-42.
3. Stanghellini V, Tosetti C, Paternico A, et al,. Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. Gastroenterology 1996; 110: 1036-42.
4. Tack J, Caenepeel P, Fischler B, Piessevaux H, Janssens J,. Symptoms associated with hypersensitivity to gastric distention in functional dyspepsia. Gastroenterology 2001; 121: 526-35.
5. Futagami S, Shindo T, Kawagoe T, et al,. Migration of eosinophils and CCR2-/CD68-double positive cells into the duodenal mucosa of patients with postinfectious dyspepsia. Am J Gastroenterol 2010; 105: 1835-42.
6. Kindt S, Tertychenyy A, de Hertogh G, Geboes K, Tack J,. Intestinal immune activation in presumed post-infectious functional dyspepsia. Neurogastroenterol Motil 2009; 21: 832-e56.
7. Dizdar V, Spiller R, Singh G, et al,. Relative importance of abnormalities of CCK and 5-HT (serotonin) in Giardia-induced post-infectious irritable bowel syndrome and functional dyspepsia. Aliment Pharmacol Ther 2010; 31: 883-91.
8. Spiller R,. Postinfectious functional dyspepsia and postinfectious irritable bowel syndrome: different symptoms but similar risk factors. Gastroenterology 2010; 138: 1660-3.
9. Mearin F, Perez-Oliveras M, Perello A, et al,. Dyspepsia and irritable bowel syndrome after a Salmonella gastroenteritis outbreak: one-year follow-up cohort study. Gastroenterology 2005; 129: 98-104.
10. Tack J, Demedts I, Dehondt G, et al,. Clinical and pathophysiological characteristics of acute-onset functional dyspepsia. Gastroenterology 2002; 122: 1738-47.
11. Bityutskiy LP, Soykan I, McCallum RW,. Viral gastroparesis: a subgroup of idiopathic gastroparesis. Clinical characteristics and long-term outcomes. Am J Gastroenterol 1997; 92: 1501-4.
12. Gwee KA, Graham JC, McKendrick MW, Collins SM, Marshall JS, Read NW,. Psychometric scores and persistence of irritable bowel after infectious diarrhoea. Lancet 1996; 347: 150-3.
13. Dunlop SP, Jenkins D, Spille RC,. Distinctive clinical, psychological, and histological features of postinfective irritable bowel syndrome. Am J Gastroenterol 2003; 98: 1578-83.
14. Spiller RC,. Inflammation as a basis for functional GI disorders. Best Pract Res Clin Gastroenterol 2004; 18: 641-61.
15. Cremon C, Stanghellini V, Pallotti F, et al,. Salmonella gastroenteritis during childhood is a risk factor for irritable bowel syndrome in adulthood. Gastroenterology 2014; 147: 69-77.
16. Porter CK, Choi D, Cash B, et al,. Pathogen-specific risk of chronic gastrointestinal disorders following bacterial causes of foodborne illness. BMC Gastroenterol 2013; 13: 46.
17. Trivedi KH, Schlett CD, Tribble DR, Monteville MR, Sanders JW, Riddle MS,. The impact of post-infectious functional gastrointestinal disorders and symptoms on the health-related quality of life of US military personnel returning from deployment to the Middle East. Dig Dis Sci 2011; 56: 3602-9.
18. Parry SD, Barton JR, Welfare MR,. Factors associated with the development of post-infectious functional gastrointestinal diseases: does smoking play a role? Eur J Gastroenterol Hepatol 2005; 17: 1071-5.
19. Tuteja AK, Talley NJ, Gelman SS, et al,. Development of functional diarrhea, constipation, irritable bowel syndrome, and dyspepsia during and after traveling outside the USA. Dig Dis Sci 2008; 53: 271-6.
20. Wang ZF, Chen HL,. Growth hormone treatment and risk of recurrence or development of secondary neoplasms in survivors of pediatric brain tumors. J Clin Nurosci 2014; pii: S0967-5868(14)00307-5. doi: 10.1016/j.jocn.2014.04.016.
21. Higgins JP, Thompson SG, Deeks J, Altman DG,. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-60.
22. Egger M, Smith GD, Schneider M, Minder C,. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-34.
23. Parry S, Stansfield R, Jelley D, et al,. Does bacterial gastroenteritis predispose people to functional gastrointestinal disorders? A prospective, community-based, case-control study. Am J Gastroenterol 2003; 98: 1970-5.
24. Ford A, Thabane M, Collins SM, et al,. Prevalence of uninvestigated dyspepsia 8 years after a large waterborne outbreak of bacterial dysentery: a cohort study. Gastroenterology 2010; 138: 1727-36.
25. Porter CK, Gormley R, Tribble DR, Cash BD, Riddle MS,. The incidence and gastrointestinal infectious risk of functional gastrointestinal disorders in a healthy US adult population. Am J Gastroenterol 2011; 106: 130-8.
26. Porter CK, Faix DJ, Shiau D, Espiritu J, Espinosa BJ, Riddle MS,. Postinfectious gastrointestinal disorders following norovirus outbreaks. Clin Infect Dis 2012; 55: 915-22.
27. Dizdar V, Gilja O, Hausken T,. Increased visceral sensitivity in Giardia-induced postinfectious irritable bowel syndrome and functional dyspepsia. Effect of the 5HT3-antagonist ondansetron. Neurogastroenterol Motil 2007; 19: 977-82.
28. Li X, Chen H, Lu H, et al,. The study on the role of inflammatory cells and mediators in post-infectious functional dyspepsia. Scand J Gastroenterol 2010; 45: 573-81.
29. Hanevik K, Hausken T, Morken MH, et al,. Persisting symptoms and duodenal inflammation related to giardia duodenitis infection. J Infect 2007; 55: 524-30.
30. Saps M, Pensabene L, Di Martino L, et al,. Post-infectious functional gastrointestinal disorders in children. J Pediatr 2008; 152: 812-6.
31. Karamanolis G, Caenepeel P, Arts J, Tack J,. Association of the predominant symptom with clinical characteristics and pathophysiological mechanisms in functional dyspepsia. Gastroenterology 2006; 130: 296-303.
32. Talley NJ, Walker MM, Aro P, et al,. Non-ulcer dyspepsia and duodenal eosinophilia: an adult endoscopic population-based case-control study. Clin Gastroenterol Hepatol 2007; 5: 1175-83.
33. Pike BL, Porter CK, Sorrell TJ, Riddle MS,. Acute gastroenteritis and the risk of functional dyspepsia: a systematic review and meta-analysis. Am J Gastroenterol 2013; 108: 1558-63.
34. Cremonini F, Talley NJ,. The overlap between functional dyspepsia and irritable bowel syndrome-a tale of one or two disorders? Aliment Pharmacol Ther 2004; 20 (Suppl. 7): 40-9.
35. Porter CK, Gloor K, Cash BD, Riddle MS,. Risk of functional gastrointestinal disorders in U.S. military following self-reported diarrhea and vomiting during deployment. Dig Dis Sci 2011; 56: 3262-9.
36. Talley NJ,. A unifying hypothesis for the functional gastrointestinal disorders: really multiple diseases or one irritable gut? Rev Gastroenterol Disord 2006; 6: 72-8.
37. Collins S, Chang C, Mearin F,. Postinfectious chronic gut dysfunction: from bench to bedside. Am J Gastroenterol 2012; 107 (Suppl. 1): 2-8.
38. Saps M, Pensabene L, Turco R, Staiano A, Cupuro D, Di Lorenzo C,. Rotavirus gastroenteritis: precursor of functional gastrointestinal disorders? J Pediatr Gastroenterol Nutr 2009; 49: 580-3.
39. Spiller RC,. Role of infection in irritable bowel syndrome. J Gastroenterol 2007; 42: 41-7.
40. Weisbrodt NW, Lai M, Bowers RL, Harari Y, Castro GA,. Structural and molecular changes in intestinal smooth muscle induced by Trichinella spiralis infection. Am J Physiol 1994; 266: G856-62.
41. Marzio L, Blennerhassett P, Chiverton S, Vermillion DL, Langer J, Collins SM,. Altered smooth muscle function in worm-free gut regions of Trichinella-infected rats. Am J Physiol 1990; 259: G306-13.
42. Moreels TG, De Man JG, De Winter BY, Timmermans JP, Herman AG, Pelckmans PA,. Effect of 2, 4, 6-trinitrobenzenesulphonic acid (TNBS)-induced ileitis on the motor function of non-inflamed rat gastric fundus. Neurogastroenterol Motil 2001; 13: 339-52.
43. Annese V, Bassotti G, Napolitano G, Usai P, Andriulli A, Vantrappen G,. Gastrointestinal motility disorders in patients with inactive Crohn's disease. Scand J Gastroenterol 1997; 32: 1107-17.
44. Mawe GM, Collins SM, Shea-Donohue T,. Changes in enteric neural circuitry and smooth muscle in the inflamed and infected gut. Neurogastroenterol Motil 2004; 16 (Suppl. 1): 133-6.
45. Jacobson K, McHugh K, Collins SM,. Experimental colitis alters myenteric nerve function at inflamed and noninflamed sites in the rat. Gastroenterology 1995; 109: 718-22.
46. Manousos ON, Salem SN,. Abnormal motility of the small intestine in ulcerative colitis. Gastroenterologia 1965; 104: 249-57.
47. Annese V, Bassotti G, Napolitano G, et al,. Gastric emptying of solids in patients with nonobstructive Crohn's disease is sometimes delayed. J Clin Gastroenterol 1995; 21: 279-82.
48. Scott RB, Gall DG, Diamant SC,. Intestinal motility during acute Yersinia enterocolitica enteritis in rabbits. Can J Physiol Pharmacol 1989; 67: 553-60.
49. Rokkas T, Pursey C, Uzoechina E, et al,. Non-ulcer dyspepsia and short term De-Nol therapy: a placebo controlled trial with particular reference to the role of Campyobacter pylori. Gut 1988; 29: 1386-91.
50. Goh KL, Parasakthi N, Peh SC, Wong NW, Lo YL, Puthucheary SD,. Helicobacter pylori infection and non-ulcer dyspepsia: the effect of treatment with colloidal bismuth subcitrate. Scand J Gastroenterol 1991; 26: 1123-31.
51. Loffeld RJ, Potters HV, Stobberingh E, Flendrig JA, van Spreeuwel JP, Arends JW,. Campylobacter associated gastritis with non-ulcer dyspepsia: a double placebo controlled trial with colloidal bismuth subcitrate. Gut 1989; 30: 1206-12.
52. Patchett S, Beattie S, Leen E, Keane C, O'Morain C,. Eradicating Helicobacter pylori and symptoms of non-ulcer dyspepsia. BMJ 1991; 303: 1238-40.
53. Stanghellini V, Barbara G, de Giorgio R, et al,. Helicobacter pylori, mucosal inflammation and symptom perception-new insights into an old hypothesis. Aliment Pharmaol Ther 2001; 15 (Suppl.): 28-32.
54. Turkkan E, Uslan I, Acarturk G, et al,. Does Helicobacter pylori-induced inflammation of gastric mucosa determine the severity of symptoms in functional dyspepsia? J Gastroenterol 2009; 44: 66-70.
55. Malfertheiner P, Mossner J, Fischbach W, et al,. Helicobacter pylori eradication is beneficial in the treatment of functional dyspepsia. Aliment Pharmacol Ther 2003; 18: 615-25.
56. Hsu PI, Lai KH, Tseng HH, et al,. Eradication of Helicobacter pylori prevents ulcer development in patients with ulcer-like functional dyspepsia. Aliment Pharmacol Ther 2001; 15: 195-201.
57. Wallaert B, Desreumaux P, Copin MC, et al,. Immunoreactivity for interleukin 3 and 5 granulocyte/macrophage colony-stimulating factor of intestinal mucosa in brochial asthma. J Exp Med 1995; 182: 1897-904.
58. Friesen CA, Andre L, Garola R, Hodge C, Roberts C,. Activated duodenal mucosal eosinophils in children with dyspepsia: a pilot transmission electron microscopic study. J Pediatr Gastroenterol Nutr 2002; 35: 329-33.
59. Toukan AU, Kamal MF, Amr SS, Arnaout MA, Abu-Romiyeh AS,. Gastroduodenal inflammation in patients with non-ulcer dyspepsia. A controlled endoscopic and morphometric study. Dig Dis Sci 1985; 30: 313-20.
60. Pires GV, Souza HS, Elia CC, et al,. Small bowel of patients with asthma and allergic rhinitis: absence of inflammation despite the presence of major cellular components of allergic inflammation. Allergy Asthma Proc 2004; 25: 253-9.
61. Zheutlin LM, Ackerman SJ, Gleich GJ, Thomas LL,. Stimulation of basophil and rat mast cell histamine release by eosinophil granule-derived cationic proteins. J Immunol 1984; 133: 2180-5.
62. Walker MM, Talley NJ, Prabhakar M, et al,. Duodenal mastocytosis, eosinophilia and intraepithelial lymphocytosis as possible disease markers in the irritable bowel syndrome and functional dyspepsia. Aliment Pharmacol Ther 2009; 29: 765-73.
63. Rothenberg ME, Hogan SP,. The eosinophil. Annu Rev Immunol 2006; 24: 147-74.
64. Murch S,. Allergy and intestinal dysmotility-evidence of genuine causal linkage? Curr Opin Gastroenterol 2006; 22: 664-8.
65. Hogan SP, Mishra A, Brandt EB, et al,. A pathological function for eotaxin and eosinophils in eosinophilic gastrointestinal inflammation. Nat Immunol 2001; 2: 353-60.
66. DeBrosse CW, Case JW, Putnam PE, Collins MH, Rothenberg ME,. Quantity and distribution of eosinophils in the gastrointestinal tract of children. Pediatr Dev Pathol 2006; 9: 210-8.
67. Vanheel H, Vicario M, Vanuytsel T, et al,. Impaired duodenal mucosal integrity and low-grade inflammation in functional dyspepsia. Gut 2014; 63: 262-71.
68. Mayer EA, Gebhart GF,. Basic and clinical aspects of visceral hyperalgesia. Gastroenterology 1994; 107: 271-93.